Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19

“Preliminary evidence suggests a possible higher incidence of diagnosis of autoimmune inflammatory rheumatic diseases (AIRDs) among patients with a history of COVID-19, but whether this association is specific to SARS-CoV-2 infection is unclear. This study compared the risk for AIRD in patients with a recent SARS-CoV-2 infection versus those with recent influenza infection and those with no infection….

Conclusion:

SARS-CoV-2 infection was associated with increased risk for incident AIRD compared with matched patients without SARS-CoV-2 infection or with influenza infection. The risk for incident AIRD was higher with greater severity of acute COVID-19.“

Kim MS et al., Long-Term Autoimmune Inflammatory Rheumatic Outcomes of CZoVID-19. A Binational Cohort Study. Annals of Internal Medicine (March 5, 2024) https://doi.org/10.7326/M23-1831

https://www.acpjournals.org/doi/10.7326/M23-1831